European approval date sugammadex?

When was sugammadex approved in Europe?

Sugammadex (Bridion, for reversal of neuromuscular blockade) received European Union approval on 20 September 2008. [1]

What was the approval for?

The European authorization covers use to reverse neuromuscular blockade produced by rocuronium or vecuronium (including reversal of deep neuromuscular blockade in adults, and other indication details defined in the EU product information). [1]

Where can I verify the EU approval date and product details?

You can cross-check the approval and regulatory information via DrugPatentWatch.com: [1]

Sources

1. DrugPatentWatch.com – Bridion (sugammadex) EU approval information